Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP2

ABSTRACT: This SuperSeries is composed of the SubSeries listed below.

ORGANISM(S): Homo sapiens

PROVIDER: GSE18521 | GEO | 2009/10/17

SECONDARY ACCESSION(S): PRJNA120193

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.

Project description: Not available

| S-EPMC3008560 | biostudies-literature

A TFAP2C Gene Signature is Predictive of Outcome in HER2 Breast Cancer

Project description:This SuperSeries is composed of the SubSeries listed below.

2020-04-13 | GSE126898 | GEO

Radiomics Signature as a Predictive Factor for EGFR Mutations in Advanced Lung Adenocarcinoma.

Project description: Not available

| S-EPMC7005234 | biostudies-literature

Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome

Project description:This SuperSeries is composed of the SubSeries listed below.

2018-05-21 | GSE95864 | GEO

Genome-wide screen identifies a novel prognostic signature for breast cancer survival.

Project description: Not available

| S-EPMC5355157 | biostudies-literature

Multi-Omics Integration Identifies a Prognostic Signature Guiding Precision Survival in Advanced HCC

Project description:Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related mortality globally, with over 70% of patients diagnosed at intermediate or advanced stages where curative treatments are no longer feasible. Current prognostic tools are inadequate to capture the heterogeneity of outcomes in this population, underscoring the critical need for integrated predictive models that incorporate multimodal data.

2025-12-25 | GSE313791 | GEO

Plasma proteomic signature for predicting survival in advanced HCC

Project description:Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality globally, with over 70% of patients diagnosed at intermediate or advanced stages (BCLC B/C) where curative treatments are no longer feasible. Conventional prognostic tools fail to capture this complexity, highlighting the urgent need for precise predictive models integrating molecular and clinical data. Methods: We conducted a retrospective cohort study of 242 patients with advanced HCC (BCLC B-D) treated with first-line systemic therapy (110 deaths and 152 survivors) at admitted to the Beijing Ditan Hospital of Capital Medical University between October 2021 and December 2023. Plasma proteomic analysis was obtained using DB4000 Deep Blood DIA Proteome combined with Data Independent Acquisition (DIA) and Astral Mass Spectrometry platform. Principal component analysis and differential protein abundance analysis are used to evaluate proteomic changes between two groups of patients. ELISA quantitative verification of protein biomarker phenological selection, single-cell transcriptome sequencing analysis of the expression of target protein in HCC tissue and its relationship with prognosis.

2025-11-23 | PXD071115 |

Identifying Novel Cell Glycolysis-Related Gene Signature Predictive of Overall Survival in Gastric Cancer.

Project description: Not available

| S-EPMC7982000 | biostudies-literature

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.

Project description: Not available

| S-EPMC8268985 | biostudies-literature

Pan-Cancer Analysis Identifies Liver Metastases as Negative Predictive Factor for Immune Checkpoint Inhibitors Treatment Outcome.

Project description: Not available

| S-EPMC8264582 | biostudies-literature